
Bortezomib treatment can lead to significant peripheral neuropathy, affecting treatment outcomes, although the exact incidence rates vary widely. Treatment cessation or modifications can sometimes ameliorate symptoms, but specific data for bortezomib use in TTP is limited.
peripheral neuropathy, TTP, complications, neurology, bortezomib, incidence, haematology, treatment outcomes
peripheral neuropathy, TTP, complications, neurology, bortezomib, incidence, haematology, treatment outcomes
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
